Adenocarcinomas of the colon and rectum are graded using a two-tiered system into histologic low-grade and high-grade tumors based on the proportion of gland formation. The current grading system does not apply to subtypes of carcinomas associated with a high frequency of microsatellite instability (MSI), such as mucinous and medullary carcinomas.
Introduction
Most colorectal carcinomas are adenocarcinomas of usual type (adenocarcinoma NOS, not otherwise specified). Since the first grading systems were established [1, 2] , pathologists have routinely included histologic grade in their reports of resected colorectal adenocarcinomas. Adenocarcinomas are graded into well-, moderately or poorly differentiated tumors (grades 1, 2, 3, respectively) depending on the proportion of gland formation in the least differentiated component of the tumor away from the invasive edge, according to the World Health Organization (WHO) criteria [3] . Despite low levels of agreement among pathologists on this subjective assessment [4, 5] , histologic grading has been shown to be an independent prognostic factor for colorectal carcinoma [6] [7] [8] [9] . This is particularly true for the poorly differentiated subgroup that has been most consistently found to be associated with adverse clinical outcome. The WHO and the American Joint Committee on Cancer (AJCC) recommend a two-tiered histologic grading system: low-grade for welland moderately differentiated adenocarcinomas (50-100% gland formation) and high-grade for poorly differentiated adenocarcinomas (0-49% gland formation) [3, 10] .
Testing tumors for microsatellite instability (MSI) by immunohistochemistry for mismatch repair (MMR) proteins MLH1, MSH2, PMS2 and MSH6 and/or by molecular-based methods is routinely performed for patients diagnosed with colorectal carcinoma, primarily to screen for Lynch syndrome. Up to 15% of all colorectal carcinomas demonstrate MSI, more frequently secondary to acquired methylation of MLH1 (sporadic cases) than caused by a germline mutation in an MMR gene (Lynch syndrome). MSI has been reported to be a strong positive prognostic factor by multiple independent studies [11] [12] [13] . Some histologic subtypes of colorectal carcinomas are more commonly observed in MSI tumors, including medullary carcinomas, mucinous adenocarcinomas and signet ring cell carcinomas [14] . The adverse
prognosis associated with the poor differentiation of most of these tumor subtypes contrasts with the positive prognosis associated with MSI. Consequently, the current WHO histologic grading does not apply to these subtypes of colorectal carcinoma. Additionally, the WHO recommends that mucinous carcinomas should be graded according to their MSI status, regardless of their morphologic appearance [3] . Such an MSI-based grading principle could potentially be applied to colorectal adenocarcinomas of usual type to more effectively stratify patients by prognosis. To test this hypothesis, we investigated the survival of a large series of patients diagnosed with colorectal adenocarcinoma with respect to histologic grade and MSI status.
Patients and Methods

Study Sample
Incident colorectal carcinomas were identified from participants enrolled of the Melbourne 
Data Collection
Clinical data were collected from medical charts, colonoscopy reports and pathology reports.
Paraffin-embedded tissue blocks were collected from hospital pathology departments where the patient underwent colectomy. Tissue sections were cut for pathology reviews, infiltrative pattern occupying >50% of the tumor. Tumors were staged using the AJCC criteria [10] .
Immunohistochemical and Molecular Analysis
Immunohistochemistry was performed on available tissue sections to assess the tumor expression of MMR proteins MLH1, PMS2, MSH2 and MSH6 [16] . MSI status was determined using a 10-loci panel in tumor DNA as previously described [17] . Tumors were MSS) for the group of adenocarcinoma only. Survival was compared between groups using the log-rank test. Cox regression models were used to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for all-cause mortality and colorectal cancerspecific mortality associated with histologic grade and MSI status, after adjusting for: sex, age at diagnosis (<60, 60-70, >70 years), and stratifying by AJCC stage since hazards were non-proportional across stages. The proportional hazards assumption was assessed using graphic methods and tests based on Schoenfeld residuals. A two-tailed P value was used for all analyses and values less than 0.05 were considered to be statistically significant. We calculated the Akaike information criterion (AIC) for each Cox model to assess goodness-offit [18] . The AIC is a method used to measure and compare the relative quality of statistical models. AIC takes into account the goodness of fit and the complexity of the model. In this context, AIC provides information on the best prognostic model using a set of variables. The lower the AIC value is, the more informative the statistical model is. There were 377 deaths during a median follow-up of 7.5 years (range 2 days to 20.4 years), of which 237 (63%) were attributed to colorectal cancer. There was evidence of significantly better overall survival and disease-specific survival for MSI tumors, compared with MSS tumors of all histologic types (P=0.038 and P=0.0003, respectively) (Figure 2 ). In the subgroup of adenocarcinoma only, there was evidence of significantly lower overall survival and disease-specific survival for high-grade MSS tumors, compared with the other three tumor groups (MSI low-grade, MSS low-grade, and MSI high-grade) (Figure 3) . When modeled together, high-grade was associated with an increased hazard for all-cause mortality and colorectal cancer-specific mortality: Hazard ratio (HR) 3.02 (95% CI, 2.32-3.92) and 4.20 (95% CI, 3.13-5.64), respectively, both P<0.001 ( Table 2) . After adjustment for sex, age and AJCC stage, MSS high-grade tumors were associated with an increased hazard for all- Similarly, for colorectal cancer-specific mortality the Cox model according to the new grading system gave the lowest most favorable AIC value.
Results
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Discussion
Our aim was to investigate the combined effect of histologic grade and MSI status on the survival of patients diagnosed with colorectal adenocarcinoma. Our finding of improved survival associated with MSI in colorectal carcinomas of any histologic subtype is consistent with previous reports [11] [12] [13] . This supports the recent WHO recommendation to grade mucinous carcinoma according to their MSI status [3] . We found that patients with high- and studies with larger numbers would be required to identify such an effect.
A grading system incorporating MSI with the traditional histologic grades would potentially affect 10-20% of all colorectal carcinomas classified as histologically high-grade adenocarcinomas. From this subgroup, 20-50% of tumors are expected to be MSI and would then be reclassified as low-grade adenocarcinomas. In this study, the proportion of MSI in high-grade adenocarcinomas was 20%, which is low compared with other studies that report up to 50% of MSI in high-grade tumors [19] . This difference may be due to the lack of standardization to define an adenocarcinoma as histologically high-grade [3, 4, 8, 20] . While the WHO clearly sets the cutoff for gland formation to 50% to separate low-grade from highgrade adenocarcinomas, it is further specified that grading is based upon the least differentiated component, with the invading edge of tumor regarded as suboptimal to evaluate tumor grade [3] . Unfortunately, the definition of the least differentiated area remains unclear and this makes comparisons between series difficult. In our study, adenocarcinomas were graded according to the area showing the least differentiated component which had to be present in at least one field at magnification x40. Using these criteria may have resulted in a Heterogeneity is frequently observed in MSI carcinomas but usually by the frequent occurrence of minor mucinous carcinoma components in an otherwise low-grade adenocarcinoma [14, 21] . The difference in proportions of high-grade adenocarcinomas is likely to be explained by the inclusion of tumors with overall <50% gland formation (i.e. suggest that the WHO grading system of adenocarcinoma may be more appropriate for patient prognostication than the AJCC/CAP system, which may undergrade tumors with a focal poorly differentiated component present in <50% of examined tumor, possibly secondary to sampling error. We propose that one microscopic field at magnification x40 away from the invading edge could be used as the minimum area containing poor differentiation for a colorectal adenocarcinoma to be classified histologically as a high-grade tumor.
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In 1986, Jass et al. [9] established a grading system using a Cox regression model based on data from 447 resected rectal adenocarcinomas. The variables that best predicted survival included tubule configuration (regular, irregular, none), lymphocytic infiltration (marked, moderate, little or none) and tumor growth pattern (expanding, infiltrating). The best score (a score of 0) was attributed to tumors showing marked lymphocytic infiltration and an expanding growth pattern. The Jass grading system was, therefore, heavily influenced by these two variables which have been subsequently found to be typical characteristics of MSI colorectal adenocarcinoma [26] . That is, our proposed criteria for integrating MSI status with the histologic grading of colorectal adenocarcinoma can be seen as a simplified version of the Jass grading system. Poor reproducibility of the Jass grading system has been reported by some authors [27] and this might have hampered its uptake by pathologists. A growing number of pathology laboratories are now implementing upfront MSI testing for all newly diagnosed colorectal carcinomas, usually by immunohistochemistry. The reliability of MMR immunohistochemistry and its good concordance with molecular methods make MSI status an easy and reproducible parameter to be widely used in pathology laboratories [28] .
Moreover, MMR immunohistochemistry has been found to be equally reliable in biopsy samples and resection specimens [29] , allowing appropriate grading at time of the initial diagnosis from the endoscopic biopsy.
In conclusion, we found that patients with colorectal adenocarcinoma are better stratified by survival when the MSI status of the tumor is incorporated in the grading system. Patients with high-grade MSI adenocarcinomas had similar survival to patients with low-grade adenocarcinomas. We propose that the grading of colorectal adenocarcinoma with high-grade histologic features, present in at least one microscopic field at magnification x40, should be made according to the MSI status of the tumor. As molecular pathology increasingly supplements morphology, pathologists will be able to integrate clinically useful biologic markers into their routine pathology practice. A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T 
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